Unique ID issued by UMIN | UMIN000021569 |
---|---|
Receipt number | R000024861 |
Scientific Title | A Phase II Study of Carbon-Ion Radiotherapy for Non-Squamous Cell Carcinoma of the Head and Neck |
Date of disclosure of the study information | 2016/03/24 |
Last modified on | 2023/12/26 11:15:49 |
A Phase II Study of Carbon-Ion Radiotherapy for Non-Squamous Cell Carcinoma of the Head and Neck
Carbon-Ion Therapy for Non-SCC of Head and Neck Tumor
A Phase II Study of Carbon-Ion Radiotherapy for Non-Squamous Cell Carcinoma of the Head and Neck
Carbon-Ion Therapy for Non-SCC of Head and Neck Tumor
Japan |
Non-squamous cell carcinoma of head and neck
Oto-rhino-laryngology | Radiology |
Malignancy
NO
To evaluate the efficacy and safety of carbon-ion radiotherapy for non-squamous cell carcinoma of head and neck, except for mucosal malignant melanoma and sarcoma
Safety,Efficacy
Confirmatory
Explanatory
Phase II
Local control rate at 3 years
1) Overall survival, Disease-specific survival
2) Early and late adverse event rate
3) Local response rate (primary treatment outcome)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
A total of 64.0 GyE of carbon-ion radiotherapy, consisting of 16 fractions of 4.0 GyE/ day for 6 to 8 times in 2 weeks
15 | years-old | <= |
80 | years-old | >= |
Male and Female
A) Non-squamous cell carcinoma of head and neck which is pathologically or cytologically diagnosed, except for malignant melanoma and sarcoma
B) Patient without lymph node metastasis or with clinical stage of N1 which can be treated by the same irradiation field as primary lesion
C) Measurable primary lesion
D) No remote metastasis
E) 0 to 2 of performance status
F) 15 years or older and 80 years or younger of age, and 6 months or longer of expected survival
G) Patient is able to understand this clinical trial and is informed for the diagnosis and disease status. And patient can be given consent with document after explanation of this trial by study personnel
A) Past history of radiotherapy for the target lesion
B) Less than two weeks after the last administration of chemotherapy
C) Active double cancer
D) Active and intractable infection in the target lesion
E) Metal devices in the target lesion which is not able to be removed
F) Patient is not suitable for this study due to medical, psychological or the other reason
54
1st name | Hiroyuki |
Middle name | |
Last name | Katoh |
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Department of Carbon-ion Radiotherapy
241-8515
2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture
045-520-2222
hkatoh@kcch.jp
1st name | Hiroyuki |
Middle name | |
Last name | Katoh |
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organizatio
Ion-beam Radiation Oncology Center
241-8515
2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture
045-520-2222
hkatoh@kcch.jp
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Self funding
Japan
None
None
Kanagawa Cancer Center IRB
2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture
045-520-2222
clinical_trials@kcch.jp
NO
神奈川県立がんセンター(神奈川県)
2016 | Year | 03 | Month | 24 | Day |
Unpublished
13
This study confirmed safety and efficacy comparable to those reported from prior facilities.
2023 | Year | 12 | Month | 26 | Day |
Completed
2016 | Year | 03 | Month | 16 | Day |
2016 | Year | 03 | Month | 17 | Day |
2016 | Year | 03 | Month | 24 | Day |
2026 | Year | 05 | Month | 31 | Day |
2026 | Year | 05 | Month | 31 | Day |
2026 | Year | 05 | Month | 31 | Day |
2027 | Year | 05 | Month | 31 | Day |
2016 | Year | 03 | Month | 22 | Day |
2023 | Year | 12 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024861